Congratulations to Dr. Dominic Hegarty (Clinical Director of Pain Relief Ireland), who gave a presentation on the issues surrounding the management of musculoskeletal pain (MSK) and what the best treatment options are. Dr. Hegarty was one of several consultants who presented the webinar. It was chaired by Sr. S. Rathi (GP, Cork) Dr. E Byrne (GP, Dublin) and hosted by the Mater Private Network had over 250 delegates registered. The Webinar aimed to update primary care physicians and physiotherapists how muscle and joint pain could be managed both surgically and non-surgically.
Dr. Hegarty specifically highlighted the epidemiology of MSK which showed that it impacts on 60% of the population. He focused on the most up to date options such as the use of Quantitive Sensory Testing (QST) to diagnosis MSK pain and highlighted three options available to improve quality of life for those with MSK pain.
These key points included
- The application of NSAIDS the newest agent available on the market Flector Diclofenac (140mg) patches. This offers the advantage of focused 12 hour treatment with little side-effects.
- The use of Platelet Rich Plasma (PRP) to accelerating recovery in refractory cases of tendinopathy and ligament injury. This offers the advantage of being able to directly apply biological healing components directly to the injured site using ultrasound guidance. It is very useful in long-standing sports injuries.
- The use of non-invasive technology, BioWave Technology to influence peripheral nerve action potentials to provide prolonged and sustained relief. This cutting-edge wearable technology offers individuals access to reliable and flexible therapy in their own home. With access to an App individual can track their improvements.
"It is important to have access to and use multi-modal therapies to help improve individuals in order to eliminate the need for long-term opioids and improve patient outcomes”
At Pain Relief Ireland are delighted to say we can offer each of these treatments to individuals with MSK pain. Dr Hegarty has extensive experience in these options having published in these areas and has established the First BioWave Pain Clinic in Europe. He tries to ensure he works with primary care physicians and physiotherapists to ensure a complete long-term management plan can be achieved. Dr. Hegarty says "It is important to have access to and use multi-modal therapies to help improve individuals in order to eliminate the need for long-term opioids and improve patient outcomes”
Information of the options are available on our information sections, and you are invited to contract Pain Relief Ireland on firstname.lastname@example.org to enquire how we can help you.
The webinar can be accessed by professionals at :